Nasus Pharma (NSRX) Earnings Date & Reports

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NSRX is expected to report earnings to fall 68.42% to -11 cents per share on December 02

Nasus Pharma NSRX Stock Earnings Reports

Q3'26

Est.

$-0.12

Q4'25

Beat

by $0.15

The last earnings report on February 25 showed earnings per share of -37 cents, beating the estimate of -52 cents. With 4.21K shares outstanding, the current market capitalization sits at 39.88M.

View a ticker or compare two or three

NSRX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for NSRX